Search Results: Ampligen

Redirect to:

  • From a page move: This is a redirect from a page that has been moved (renamed). This page was kept as a redirect to avoid breaking links, both internal and external, that may have been made to the old page name.

Rintatolimod
Senin, 2026-07-27 03:22:24

Rintatolimod, sold under the tradename Ampligen, is a medication intended for treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)...

Click to read more »
AIM ImmunoTech
Senin, 2026-06-15 18:42:19

created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types,...

Click to read more »
List of antiviral drugs
Minggu, 2026-08-09 02:40:09

Amantadine Influenza Influenza A virus M2 proton channel antagonist 1966 Ampligen Avian Influenza Immunomodulatory double-stranded RNA 2016 (Argentina) Amprenavir...

Click to read more »
Daniel Peterson (physician)
Minggu, 2026-06-07 05:42:00

patients receiving Ampligen. He is a principal investigator of the FDA-approved open-label safety and efficacy phase III drug study of Ampligen for treatment...

Click to read more »
List of investigational ME/CFS drugs
Selasa, 2026-07-28 21:50:59

norepinephrine–dopamine reuptake inhibitor Rintatolimod (AMP-516; AMP-518; Ampligen; Atvogen; Rintamod; PolyI:PolyC12U) – mismatched double-stranded polymer...

Click to read more »
Management of ME/CFS
Senin, 2026-07-13 00:43:18

chronic fatigue drug Ampligen". Philadelphia Business Journal. Retrieved 2010-02-12. "FDA Response Letter Regarding Approval of Ampligen for ME/CFS". FDA...

Click to read more »
List of investigational long COVID drugs
Rabu, 2026-07-29 10:28:17

and interleukin-15 receptor agonist [9] Rintatolimod (AMP-516; AMP-518; Ampligen; Atvogen; Rintamod; PolyI:PolyC12U) – mismatched double-stranded polymer...

Click to read more »
Whittemore Peterson Institute
Rabu, 2026-07-22 21:11:38

Peterson with the experimental antiviral drug Ampligen. Hemispherx's new drug application for Ampligen, which permits sale and marketing, was rejected...

Click to read more »